Masimo Corporation Intrinsic Stock Value – MASIMO CORPORATION Reports Earnings Results for Second Quarter of FY2023

August 16, 2023

🌥️Earnings Overview

On August 8 2023, Masimo Corporation ($NASDAQ:MASI) released their earnings report for the second quarter of FY2023, ending June 30 2023. Overall revenue totalled USD 455.3 million, a dip of 19.5% from the same quarter of FY2022. Net income dropped 13.3% year over year to USD 15.7 million.

Share Price

The stock opened at $122.1 and closed at $120.0, representing a 2.4% decrease from the previous day’s closing price of 123.0. The company attributed much of their success to improved efficiency and cost control measures resulting in increased profitability.

Additionally, their investments in research and development are paying off as they have launched several new products this quarter to great success. All in all, the second quarter of FY2023 was a positive one for MASIMO CORPORATION, with investors encouraged by their financial performance. This bodes well for the future of the company, as they look set to continue their strong growth trajectory. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Masimo Corporation. More…

    Total Revenues Net Income Net Margin
    2.19k 115.8 5.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Masimo Corporation. More…

    Operations Investing Financing
    27.8 -64 -15.5
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Masimo Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    3.01k 1.7k 24.77
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Masimo Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    27.8% -7.1% 9.3%
    FCF Margin ROE ROA
    -1.3% 9.6% 4.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Masimo Corporation Intrinsic Stock Value

    GoodWhale is proud to analyze the financials of MASIMO CORPORATION. After running our proprietary Valuation Line, the intrinsic value for MASIMO CORPORATION’s share is estimated at $329.6. However, the current stock price is trading at $120.0, marking a 63.6% undervaluation. This represents a great opportunity for investors to purchase shares of MASIMO CORPORATION at a discounted price. Investors should take full advantage of this situation and purchase shares of MASIMO CORPORATION before the stock returns to its intrinsic value. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    In the medical device industry, there is intense competition between Masimo Corp and its rivals Elekta AB, Essilorluxottica, and Compumedics Ltd. While all four companies offer innovative products and services, each has its own unique strengths and weaknesses. As a result, the competition between them is fierce, and it is often difficult for one company to gain a significant advantage over the others.

    – Elekta AB ($OTCPK:EKTAY)

    Despite a challenging year for the company, Elekta’s market cap has grown to 2.09B as of 2022. This is due in part to the company’s strong return on equity, which stands at 11.86%. Elekta is a leading provider of radiation therapy solutions for the treatment of cancer. The company’s products are used in over 6,000 hospitals and clinics around the world, and its solutions are backed by a team of over 3,000 employees.

    – Essilorluxottica ($LTS:0OMK)

    EssilorLuxottica is a French-Italian multinational corporation that designs, manufactures, and markets ophthalmic lenses, instruments, and equipment. The company has a presence in over 130 countries and employs more than 140,000 people. The company was formed in 2018 through the merger of Essilor International and Luxottica.

    – Compumedics Ltd ($ASX:CMP)

    Computedics Ltd is a technology company that provides computing and analytics solutions. The company has a market cap of 42.52M as of 2022 and a Return on Equity of 1.53%. Computedics Ltd provides computing and analytics solutions to businesses and organizations worldwide. The company offers a range of services, including data storage, cloud computing, data analysis, and security. Computedics Ltd is headquartered in Sydney, Australia.


    This report on MASIMO CORPORATION revealed a 19.5% decrease in total revenue in the second quarter of FY2023, compared to the same period in the previous year. Net income also decreased 13.3% year over year, amounting to USD 15.7 million. For investors, this data suggests that despite a challenging market, MASIMO CORPORATION is remaining resilient, having achieved a modest decrease in earnings. As the company continues to adjust to the current market climate, investors should closely watch for future financial updates to gauge its performance and determine if the current financial state warrants further investment.

    Recent Posts

    Leave a Comment